Trials / Terminated
TerminatedNCT01404221
Biochemical Markers and 2 and 3D Ultrasound to ID Maternal & Fetal Complications
The Combination of Biochemical Markers and Two and Three Dimensional Ultrasound Using Geometric Morphometrics in the Identification of Congenital Anomalies and Maternal or Fetal Complications
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 350 (actual)
- Sponsor
- Northwell Health · Academic / Other
- Sex
- Female
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
Can a combination of prenatal screening blood tests, early ultrasound, and a 3D ultrasound of the fetal face at approximately 20 weeks gestation identify fetuses with congenital anomalies and predict maternal and fetal complications?
Detailed description
Pts will be consented upon presenting to the department for a comprehensive ultrasound.The 3D picture is the only part of the study that is not part of standard obstetrical care.
Conditions
Timeline
- Start date
- 2009-03-01
- Primary completion
- 2015-02-01
- Completion
- 2015-02-01
- First posted
- 2011-07-27
- Last updated
- 2015-04-14
Source: ClinicalTrials.gov record NCT01404221. Inclusion in this directory is not an endorsement.